IGF::OT::IGF Topic 372 - SBIR Phase I: Development and Validation of Non- Mouse Reagents to Enable Preclinical Development of Novel Therapeutics - Moonshot
IGF::OT::IGF 主题 372 - SBIR 第一阶段:开发和验证非小鼠试剂以实现新型疗法的临床前开发 - Moonshot
基本信息
- 批准号:9795158
- 负责人:
- 金额:$ 29.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-17 至 2019-06-16
- 项目状态:已结题
- 来源:
- 关键词:AffinityAntibodiesAntigensBindingBiological MarkersBiological ModelsCanis familiarisCellsDevelopmentEnzyme-Linked Immunosorbent AssayExhibitsExtracellular DomainFutureHumanImmune responseImmune systemImmunizationImmunizeImmunoassayImmunotherapeutic agentIndividualInterferon Type IIInterferonsLibrariesMalignant NeoplasmsMentorsMonoclonal AntibodiesNON MouseOryctolagus cuniculusOutcomePDCD1LG1 genePeptidesPhaseReagentRecombinantsSLEB2 geneSmall Business Innovation Research GrantSpecificitySplenocyteTestingTherapeuticTissuesValidationYeastsanti-PD-1antibody librariesin vivomouse modelnovel therapeuticsoncologyphase 1 studypreclinical developmentresponse
项目摘要
There is an increasing appreciation that dogs with naturally occurring cancers may be a better model system for evaluating cancer therapeutics than the traditional mouse model systems. However, use of dogs for evaluating the emerging class of immunotherapeutics for oncology is limited by the availability of suitable reagents to mentor the response of the canine immune system. The majority of reagents for canine markers that are currently available are rabbit polyclonal reagents, which are not renewable and suffer from lot-to-lot variability. In this Phase I study we propose to use our proprietary yeast antibody display platform to generate rabbit monoclonal antibodies (mAbs) against 3 canine markers, CD3e, PD-L 1 and IFN-gamma to demonstrate the power of our approach to generate high affinity, highly specific rabbit mAbs. In parallel we plan to screen our existing fully-human antibody libraries to isolate a function-blocking anti-canine PD-1 Antibody that also cross-reads with human PD-1 as a prototypic canine immunotherapeutic to be used in Phase II to assess in vivo immune responses using all the reagents generated during this project A successful outcome will result in a panel of high quality, well characterized and renewable reagents for canine biomarkers that will facilitate future development of immunotherapeutics.
人们越来越认识到,与传统的小鼠模型系统相比,患有自然发生的癌症的狗可能是用于评估癌症治疗的更好的模型系统。然而,使用犬评价肿瘤学免疫治疗的新兴类别受到指导犬免疫系统反应的合适试剂的可用性的限制。目前可获得的用于犬标记物的大多数试剂是兔多克隆试剂,其不可再生并且存在批次间变异性。在该I期研究中,我们建议使用我们的专有酵母抗体展示平台来产生针对3种犬标志物(CD 3e、PD-L 1和IFN-γ)的兔单克隆抗体(mAb),以证明我们的方法产生高亲和力、高特异性兔mAb的能力。同时,我们计划筛选我们现有的全人抗体文库,以分离功能阻断抗犬PD-1抗体,该抗体也与人PD-1交叉读取,作为原型犬免疫素用于II期,以使用本项目期间产生的所有试剂评估体内免疫应答。成功的结果将产生高质量的一组,用于犬生物标志物的良好表征和可再生的试剂将促进免疫治疗剂的未来发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
XIAOMIN FAN其他文献
XIAOMIN FAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('XIAOMIN FAN', 18)}}的其他基金
DEVELOPMENT OF RABBIT MONOCLONAL ANTIBODIES FOR FERRET BIOMARKERS
雪貂生物标志物兔单克隆抗体的开发
- 批准号:
10470554 - 财政年份:2021
- 资助金额:
$ 29.99万 - 项目类别:
Development and validation of anti-canine reagents to enable pre-clinical development of novel therapeutics
抗犬试剂的开发和验证,以实现新型疗法的临床前开发
- 批准号:
10267452 - 财政年份:2020
- 资助金额:
$ 29.99万 - 项目类别:
Developing a highly specific and sensitive glucagon ELISA kit
开发高度特异性和敏感性的胰高血糖素 ELISA 试剂盒
- 批准号:
8974749 - 财政年份:2015
- 资助金额:
$ 29.99万 - 项目类别:
Novel platform for isolation of rabbit monoclonal antibodies against modified RNA bases
用于分离针对修饰 RNA 碱基的兔单克隆抗体的新平台
- 批准号:
8841274 - 财政年份:2014
- 资助金额:
$ 29.99万 - 项目类别:
TOPIC 319 PHASE I; RECOMBINANT RABBIT MONOCLONAL ANTIBODIES AS AFFINITY CAPTURES
主题 319 第一阶段;
- 批准号:
8762826 - 财政年份:2013
- 资助金额:
$ 29.99万 - 项目类别:
OTHER FUNCTIONS - RECOMBINANT ANTIBODIES AS AFFINITY CAPTURES
其他功能 - 重组抗体作为亲和力捕获
- 批准号:
8564131 - 财政年份:2012
- 资助金额:
$ 29.99万 - 项目类别:
A novel approach for developing GPCR subtype specific antibodies
开发 GPCR 亚型特异性抗体的新方法
- 批准号:
8198932 - 财政年份:2011
- 资助金额:
$ 29.99万 - 项目类别:
A novel approach for developing GPCR subtype specific antibodies
开发 GPCR 亚型特异性抗体的新方法
- 批准号:
8330248 - 财政年份:2011
- 资助金额:
$ 29.99万 - 项目类别:
TAS::75 0893::TAS RENEWABLE CAPTURES FOR ADDICTION-RELEVANT PROTEINS
TAS::75 0893::TAS 可再生捕获成瘾相关蛋白质
- 批准号:
8432390 - 财政年份:2010
- 资助金额:
$ 29.99万 - 项目类别:
TAS::75 0893::TAS RENEWABLE CAPTURES FOR ADDICTION-RELEVANT PROTEINS
TAS::75 0893::TAS 可再生捕获成瘾相关蛋白质
- 批准号:
8164231 - 财政年份:2010
- 资助金额:
$ 29.99万 - 项目类别:
相似海外基金
Rationally guided discovery platform for monoclonal antibodies against carbohydrate antigens using virus-like particle conjugate immunization and high throughput selection
使用病毒样颗粒缀合物免疫和高通量选择的合理引导的针对碳水化合物抗原的单克隆抗体的发现平台
- 批准号:
10574738 - 财政年份:2023
- 资助金额:
$ 29.99万 - 项目类别:
Assessing the role of liver stage antigens-specific antibodies against Plasmodium falciparum liver stage infection
评估肝期抗原特异性抗体对抗恶性疟原虫肝期感染的作用
- 批准号:
10392870 - 财政年份:2021
- 资助金额:
$ 29.99万 - 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
- 批准号:
10092930 - 财政年份:2020
- 资助金额:
$ 29.99万 - 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
- 批准号:
9896170 - 财政年份:2020
- 资助金额:
$ 29.99万 - 项目类别:
Interrogation of cell surface antigens on B lineage cells using structurally unique variable lymphocyte receptor antibodies of the evolutionarily distant sea lamprey
使用进化遥远的海七鳃鳗结构独特的可变淋巴细胞受体抗体询问 B 谱系细胞上的细胞表面抗原
- 批准号:
433456 - 财政年份:2020
- 资助金额:
$ 29.99万 - 项目类别:
Operating Grants
Investigations of interactions between various natural antibodies and food-derived antigens
研究各种天然抗体与食物源性抗原之间的相互作用
- 批准号:
19K15765 - 财政年份:2019
- 资助金额:
$ 29.99万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Identifying Kawasaki Disease-Specific Antibodies and Antigens
识别川崎病特异性抗体和抗原
- 批准号:
9932769 - 财政年份:2018
- 资助金额:
$ 29.99万 - 项目类别:
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
- 批准号:
BB/P504713/1 - 财政年份:2017
- 资助金额:
$ 29.99万 - 项目类别:
Training Grant
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
- 批准号:
1932904 - 财政年份:2017
- 资助金额:
$ 29.99万 - 项目类别:
Studentship
SBIR Phase II: Automated Design Methods of Antibodies Directed to Protein and Carbohydrate Antigens
SBIR II 期:针对蛋白质和碳水化合物抗原的抗体的自动化设计方法
- 批准号:
1632399 - 财政年份:2016
- 资助金额:
$ 29.99万 - 项目类别:
Standard Grant